INS and metabolic dysfunction-associated steatotic liver disease: IR is characterized as a state of decreased responsiveness of insulin-targeting tissues to high physiological insulin levels and is considered the pathogenic driver of numerous cardiovascular diseases, nonalcoholic fatty liver disease (NAFLD), and type 2 diabetes mellitus (T2DM) (Lee et al. 2022).